Search Results - "Wollborn, Laura"

Serum miRNA improves the accuracy of a multivariate index assay for triage of an adnexal mass by Webber, James W., Wollborn, Laura, Mishra, Sudhanshu, Vitonis, Allison F., Cramer, Daniel W., Phan, Ryan T., Pappas, Todd C., Stawiski, Konrad, Fendler, Wojciech, Chowdhury, Dipanjan, Elias, Kevin M.

“…To determine whether a multimodal assay combining serum microRNA with protein biomarkers and metadata improves triage assessment of an adnexal mass. Serum…”
Get full text

Effects of clinical covariates on serum miRNA expression among women without ovarian cancer by Wollborn, Laura, Webber, James W, Alimena, Stephanie, Mishra, Sudhanshu, Sussman, Chad B, Comrie, Cameron Elizabeth, Packard, Daniel George, Williams, Marta, Russell, Trinity, Fendler, Wojciech, Chowdhury, Dipanjan, Elias, Kevin M

“…Serum microRNAs (miRNAs) are potential biomarkers for ovarian cancer; however, many factors may influence miRNA expression. To understand potential confounders…”
Get full text

Abstract B048: Evaluating the impact of pulmonary diseases on the use of microRNAs as biomarkers for early detection of ovarian cancer by Moore, Monica, Wollborn, Laura, Mishra, Sudhanshu, Webber, James, Elias, Kevin M.

“…Background: Efforts are ongoing to develop new biomarkers to diagnose ovarian cancer at earlier, more curable stages. microRNAs (miRNAs) have emerged as a…”
Get full text

Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test by Alimena, Stephanie, Stephenson, Briana Joy K, Webber, James W, Wollborn, Laura, Sussman, Chad B, Packard, Daniel George, Williams, Marta, Comrie, Cameron Elizabeth, Wang, Joyce Y, Markert, Tahireh, Spiegel, Julia, Rodriguez, Carmen B, Lightfoot, Maya, Graye, Amia, O'Connor, Sean, Elias, Kevin M

“…Serum miRNAs are promising biomarkers for several clinical conditions, including ovarian cancer. To inform equitable implementation of these tests, we…”
Get more information

Abstract 3896: Time to diagnosis analysis using miRNA-based ovarian cancer prediction models by Webber, James, Wollborn, Laura, Mishra, Sudhanshu, Alimena, Stephanie, Testino, Bryanna, Vitonis, Allison, Cramer, Daniel, Chowdhury, Dipanjan, Elias, Kevin

“…Background: The recent literature proposes several diagnostic Machine Learning (ML) models for ovarian cancer based on miRNA expression profiling. These ML…”
Get full text

Abstract A045: Improving the diagnostic accuracy of an ovarian cancer triage test using a joint miRNA-protein model by Webber, James W., Wollborn, Laura, Mishra, Sudhanshu, Vitonis, Allison, Cramer, Daniel W., Phan, Ryan, Pappas, Todd, Chowdhury, Dipanjan, Elias, Kevin M.

“…Background: Multianalyte protein assays that combine several protein biomarkers with an individual’s menopausal status can aid in the preoperative prediction…”
Get full text

Abstract PR001: Assessing differences in miRNA profiles by race and ethnicity: Implications for creating an equitable ovarian cancer early detection test by Alimena, Stephanie, Webber, James, Wollborn, Laura, Williams, Marta, Sussman, Chad B., Wang, Joyce Y., Spiegel, Julia, Elias, Kevin M.

“…Introduction: Assessing serum micro RNA (miRNA) profiles is an emerging technique for earlier detection of ovarian cancer. A panel of miRNAs for ovarian cancer…”
Get full text

Abstract B044: Serum miRNA expression in ovarian cancer patients is independent of histological subtype and FIGO stage by Wollborn, Laura, Webber, James W., Mishra, Sudhanshu, Sussman, Chad B., Comrie, Cameron E., Packard, Daniel G., Vitonis, Allison, Alimena, Stephanie, Phan, Ryan, Pappas, Todd, Cramer, Daniel W., Chowdhury, Dipanjan, Elias, Kevin M.

“…Background: Serum miRNAs have been proposed as potential biomarkers for the early detection of ovarian cancer (OC). The heterogenous histological subtypes of…”
Get full text